Moser Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$248K Sell
3,135
-629
-17% -$50K 0.12% 78
2025
Q1
$338K Buy
3,764
+9
+0.2% +$840 0.18% 73
2024
Q4
$374K Sell
3,755
-750
-17% -$77.3K 0.19% 64
2024
Q3
$512K Hold
4,505
0.27% 60
2024
Q2
$558K Hold
4,505
0.3% 56
2024
Q1
$594K Sell
4,505
-260
-5% -$32K 0.33% 54
2023
Q4
$519K Hold
4,765
0.33% 54
2023
Q3
$491K Hold
4,765
0.34% 52
2023
Q2
$550K Buy
+4,765
New +$541K 0.37% 51
2022
Q4
$590K Hold
5,315
0.44% 49
2022
Q3
$458K Hold
5,315
0.36% 52
2022
Q2
$485K Hold
5,315
0.36% 52
2022
Q1
$436K Hold
5,315
0.27% 58
2021
Q4
$407K Hold
5,315
0.25% 58
2021
Q3
$399K Sell
5,315
-800
-13% -$60.8K 0.26% 60
2021
Q2
$476K Sell
6,115
-294
-5% -$21.9K 0.31% 57
2021
Q1
$471K Buy
6,409
+210
+3% +$15.5K 0.33% 53
2020
Q4
$484K Hold
6,199
0.36% 50
2020
Q3
$491K Buy
6,199
+2,521
+69% +$197K 0.39% 43
2020
Q2
$271K Buy
3,678
+2,997
+440% +$226K 0.26% 47
2020
Q1
$50K Hold
681
0.06% 73
2019
Q4
$59K Buy
+681
New +$55.9K 0.06% 81

Other funds holding MRK

Moser Wealth Advisors's MRK Position: Q2 2025 in Review

Moser Wealth Advisors reduced its Merck (MRK) stake by 17% in Q2 2025, selling an estimated $50K and leaving 3,135 shares worth $248K. The position accounts for 0.12% of the portfolio, ranked #78.

Moser Wealth Advisors first reported a position in MRK in Q4 2019 and has held it in 22 quarters since. The position peaked at $594K in Q1 2024. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • Moser Wealth Advisors held 3,135 shares of Merck worth $248K as of Q2 2025.
  • Moser Wealth Advisors sold 629 Merck shares in Q2 2025, an estimated $50K.
  • Merck made up 0.12% of Moser Wealth Advisors's portfolio in Q2 2025, its #78 holding.
  • Moser Wealth Advisors first reported a position in Merck in Q4 2019 and has held it in 22 quarters since.
  • Moser Wealth Advisors's Merck position peaked at $594K in Q1 2024.
  • 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Moser Wealth Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.